Related references
Note: Only part of the references are listed.Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation
A. Sadanandam et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
Paolo Cirri et al.
CANCER AND METASTASIS REVIEWS (2012)
Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity
Rodrigo Leite de Oliveira et al.
CANCER CELL (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Emerging Role of Semaphorins as Major Regulatory Signals and Potential Therapeutic Targets in Cancer
Luca Tamagnone
CANCER CELL (2012)
Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
A. Gregory Sorensen et al.
CANCER RESEARCH (2012)
Neuropilin-1 Stimulates Tumor Growth by Increasing Fibronectin Fibril Assembly in the Tumor Microenvironment
Usman Yaqoob et al.
CANCER RESEARCH (2012)
Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer
Atsuko Sakurai et al.
CELL RESEARCH (2012)
Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer (vol 22, pg 23, 2012)
Atsuko Sakurai et al.
CELL RESEARCH (2012)
The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling
Chiara Sandri et al.
CELL RESEARCH (2012)
Semaphorin3A, Neuropilin-1, and PlexinA1 Are Required for Lymphatic Valve Formation
Karine Bouvree et al.
CIRCULATION RESEARCH (2012)
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform
Andrea Casazza et al.
EMBO MOLECULAR MEDICINE (2012)
Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1
Matthew W. Parker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
Federica Maione et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages
Claudia Meda et al.
JOURNAL OF IMMUNOLOGY (2012)
The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities
Michele De Palma et al.
MOLECULAR ONCOLOGY (2012)
Osteoprotection by semaphorin 3A
Mikihito Hayashi et al.
NATURE (2012)
Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite formation in the neocortex
Froylan Calderon de Anda et al.
NATURE NEUROSCIENCE (2012)
Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
Annamaria Rapisarda et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model
Goutam Chakraborty et al.
PLOS ONE (2012)
Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948)
Chandrajit P. Raut et al.
PLOS ONE (2012)
TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
Jieqiong Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Semaphorin Signaling Meets Rap
Johannes L. Bos et al.
SCIENCE SIGNALING (2012)
Plexins Are GTPase-Activating Proteins for Rap and Are Activated by Induced Dimerization
Yuxiao Wang et al.
SCIENCE SIGNALING (2012)
Diverse roles for semaphorin-plexin signaling in the immune system
Hyota Takamatsu et al.
TRENDS IN IMMUNOLOGY (2012)
Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
Barbara Sennino et al.
CANCER DISCOVERY (2012)
Semaphorins in Angiogenesis and Tumor Progression
Gera Neufeld et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
Shom Goel et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
SEMA3A, a Gene Involved in Axonal Pathfinding, Is Mutated in Patients with Kallmann Syndrome
Naresh Kumar Hanchate et al.
PLOS GENETICS (2012)
Merlin/NF2 Regulates Angiogenesis in Schwannomas through a Rac1/Semaphorin 3F-Dependent Mechanism
Hon-Kit Wong et al.
NEOPLASIA (2012)
Controlling escape from angiogenesis inhibitors
Barbara Sennino et al.
NATURE REVIEWS CANCER (2012)
Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models
Andrea Casazza et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling
Boaz Kigel et al.
BLOOD (2011)
HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PIGF
Charlotte Rolny et al.
CANCER CELL (2011)
Polarization of Tumor-Associated Macrophages: A Novel Strategy for Vascular Normalization and Antitumor Immunity
Yuhui Huang et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
PDGF-D Improves Drug Delivery and Efficacy via Vascular Normalization, But Promotes Lymphatic Metastasis by Activating CXCR4 in Breast Cancer
Jieqiong Liu et al.
CLINICAL CANCER RESEARCH (2011)
Evolutionary origins of oxygen sensing in animals
Kalle T. Rytkonen et al.
EMBO REPORTS (2011)
Cancer-promoting tumor-associated macrophages: New vistas and open questions
Alberto Mantovani et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Nervous vascular parallels: axon guidance and beyond
Marco Arese et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
An Intact Canonical NF-κB Pathway Is Required for Inflammatory Gene Expression in Response to Hypoxia
Susan F. Fitzpatrick et al.
JOURNAL OF IMMUNOLOGY (2011)
Macrophage regulation of tumor angiogenesis: Implications for cancer therapy
Mario Leonardo Squadrito et al.
MOLECULAR ASPECTS OF MEDICINE (2011)
Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer
Sonia Tugues et al.
MOLECULAR ASPECTS OF MEDICINE (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?
Katrien De Bock et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
Mechanisms and Molecules of Neuronal Wiring: A Primer
Alex L. Kolodkin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Furin Processing of Semaphorin 3F Determines Its Anti-Angiogenic Activity by Regulating Direct Binding and Competition for Neuropilin
Matthew W. Parker et al.
BIOCHEMISTRY (2010)
Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branching
Geraldine A. Strasser et al.
BLOOD (2010)
Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma
K. K. Y. Cham et al.
BRITISH JOURNAL OF CANCER (2010)
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
Neta Erez et al.
CANCER CELL (2010)
Anti-Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
Hon Kit Wong et al.
CANCER RESEARCH (2010)
Id2 Promotes Tumor Cell Migration and Invasion through Transcriptional Repression of Semaphorin 3F
Silvia Coma et al.
CANCER RESEARCH (2010)
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Rajeev K. Shrimali et al.
CANCER RESEARCH (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Inhibition of Semaphorin As a Novel Strategy for Therapeutic Angiogenesis
Junji Moriya et al.
CIRCULATION RESEARCH (2010)
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Alberto Mantovani et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
Amir Abdollahi et al.
DRUG RESISTANCE UPDATES (2010)
Autocrine Semaphorin3A stimulates eukaryotic initiation factor 4E-dependent RhoA translation in breast tumor cells
Hongjie Pan et al.
EXPERIMENTAL CELL RESEARCH (2010)
Hallmarks of cancer: Interactions with the tumor stroma
Kristian Pietras et al.
EXPERIMENTAL CELL RESEARCH (2010)
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
Vasilena Gocheva et al.
GENES & DEVELOPMENT (2010)
High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis
Anguraj Sadanandam et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
IMPROVED INTRATUMORAL OXYGENATION THROUGH VASCULAR NORMALIZATION INCREASES GLIOMA SENSITIVITY TO IONIZING RADIATION
Mackenzie C. McGee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Neuropilin-1 Mediates Divergent R-Smad Signaling and the Myofibroblast Phenotype
Ying Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Anti-Angiogenic Therapy: Adapting Strategies to Overcome Resistant Tumors
Dianne C. Mitchell et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice
Andrea Casazza et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Phase II Study of Cediranib, an Oral Pan-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A Forward Genetic Screen in Mice Identifies Sema3AK108N, which Binds to Neuropilin-1 but Cannot Signal
Janna Merte et al.
JOURNAL OF NEUROSCIENCE (2010)
Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis
Anguraj Sadanandam et al.
MICROVASCULAR RESEARCH (2010)
Semaphorin 3E Initiates Antiangiogenic Signaling through Plexin D1 by Regulating Arf6 and R-Ras
Atsuko Sakurai et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Mechanism of Hypoxia-Induced NF-κB
Carolyn Culver et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Mechanisms of Motility in Metastasizing Cells
Mahmut Yilmaz et al.
MOLECULAR CANCER RESEARCH (2010)
Structural basis for semaphorin signalling through the plexin receptor
Terukazu Nogi et al.
NATURE (2010)
The final steps of integrin activation: the end game
Sanford J. Shattil et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
VEGFR2 (KDR/Flk1) Signaling Mediates Axon Growth in Response to Semaphorin 3E in the Developing Brain
Anais Bellon et al.
NEURON (2010)
Semaphorins and tumor angiogenesis
Guido Serini et al.
ANGIOGENESIS (2009)
Vascular Endothelial Growth Factor
Napoleone Ferrara
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood resident monocytes, and embryonic macrophages suggests common functions and developmental relationships
Ferdinando Pucci et al.
BLOOD (2009)
PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
Yongping Crawford et al.
CANCER CELL (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Semaphorins and their receptors in lung cancer
Vincent A. Potiron et al.
CANCER LETTERS (2009)
Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling
Naseer Qayum et al.
CANCER RESEARCH (2009)
A Vascular Normalization Index as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
A. Gregory Sorensen et al.
CANCER RESEARCH (2009)
Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
Massimiliano Mazzone et al.
CELL (2009)
Hypoxia, angiogenesis and cancer therapy To breathe or not to breathe?
Paolo Michieli
CELL CYCLE (2009)
Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
John M. L. Ebos et al.
CLINICAL CANCER RESEARCH (2009)
Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Wei Wang et al.
CLINICAL CANCER RESEARCH (2009)
Semaphorin signalling
Rachel E. Jackson et al.
CURRENT BIOLOGY (2009)
Neuropilin receptors guide distinct phases of sensory and motor neuronal segmentation
Julaine Roffers-Agarwal et al.
DEVELOPMENT (2009)
Neuropilin-mediated neural crest cell guidance is essential to organise sensory neurons into segmented dorsal root ganglia
Quenten Schwarz et al.
DEVELOPMENT (2009)
Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development
Kimberly J. Reidy et al.
DEVELOPMENT (2009)
The Role of Hypoxia in Development of the Mammalian Embryo
Sally L. Dunwoodie
DEVELOPMENTAL CELL (2009)
Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies
Annamaria Rapisarda et al.
DRUG RESISTANCE UPDATES (2009)
Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages
Jong-Dae Ji et al.
HUMAN IMMUNOLOGY (2009)
Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis
Maria Galluzzo et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system
Hellmut G. Augustin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model
Qingyu Zhou et al.
NEURO-ONCOLOGY (2009)
Role and Therapeutic Potential of VEGF in the Nervous System
Carmen Ruiz De Almodovar et al.
PHYSIOLOGICAL REVIEWS (2009)
Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy
George J. Cerniglia et al.
PLOS ONE (2009)
Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
Debbie Liao et al.
PLOS ONE (2009)
ZEB-1, a Repressor of the Semaphorin 3F Tumor Suppressor Gene in Lung Cancer Cells
Jonathan Clarhaut et al.
NEOPLASIA (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Semaphorin 3E Expression Correlates Inversely with Plexin D1 During Tumor Progression
Ilse Roodink et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor
Lisette M. Acevedo et al.
BLOOD (2008)
Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases
Asya Varshavsky et al.
CANCER RESEARCH (2008)
Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide
Qingyu Zhou et al.
CLINICAL CANCER RESEARCH (2008)
Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis
Guido Serini et al.
CURRENT OPINION IN HEMATOLOGY (2008)
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
Michele Sabbah et al.
DRUG RESISTANCE UPDATES (2008)
NF-kappa B Signaling Pathway and Its Therapeutic Implications in Human Diseases
Fazlul H. Sarkar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2008)
NF-κB and epithelial to mesenchymal transition of cancer
Chengyin Min et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment
Charlotte Rolny et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages
Jose Rafael Sierra et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Juliana Hamzah et al.
NATURE (2008)
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
Christian Stockmann et al.
NATURE (2008)
Perivascular nitric oxide gradients normalize tumor vasculature
Satoshi Kashiwagi et al.
NATURE MEDICINE (2008)
High-grade glioma before and after treatment with radiation and Avastin: Initial observations
Ingeborg Fischer et al.
NEURO-ONCOLOGY (2008)
Semaphorin signaling: progress made and promises ahead
Yeping Zhou et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
The semaphorins: versatile regulators of tumour progression and tumour angiogenesis
Gera Neufeld et al.
NATURE REVIEWS CANCER (2008)
Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer
Rakesh K. Jain
NATURE REVIEWS CANCER (2008)
Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development
Sophie Chauvet et al.
NEURON (2007)
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
Farbod Shojaei et al.
NATURE (2007)
Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: A feasibility study
Elizabeth Bullitt et al.
RADIOLOGY (2007)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding
Brent A. Appleton et al.
EMBO JOURNAL (2007)
Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis
Noga Guttmann-Raviv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Site-directed mutagenesis in the b-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F
Elena Geretti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content
Marya F. McCarty et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Revacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy
Paxton V. Dickson et al.
CLINICAL CANCER RESEARCH (2007)
VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects
Dan G. Duda et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization
Ruud P. M. Dings et al.
CLINICAL CANCER RESEARCH (2007)
Selective requirements for NRP1 ligands during neurovascular patterning
Joaquim Miguel Vieira et al.
DEVELOPMENT (2007)
Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1
Toshihiko Toyofuku et al.
EMBO JOURNAL (2007)
Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p2l1.3, in p53-regulated tumor angiogenesis suppression
Manabu Futamura et al.
CANCER RESEARCH (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Interferon beta-mediated vessel stabilization improves delivery and efficacy of systemically administered topotecan in a murine neuroblastoma model
Paxton V. Dickson et al.
JOURNAL OF PEDIATRIC SURGERY (2007)
Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: Importance of optimal scheduling to exploit the 'normalization' window of the tumor vasculature
Jerome Segers et al.
CANCER LETTERS (2006)
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma
Angelo Vacca et al.
BLOOD (2006)
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis
Hiroaki Nozawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis
John R. Basile et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Nitric oxide signaling: no longer simply on or off
SPL Cary et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
RK Jain et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
FARP2 triggers signals for Sema3A-mediated axonal repulsion
T Toyofuku et al.
NATURE NEUROSCIENCE (2005)
The origins and uses of mouse outbred stocks
R Chia et al.
NATURE GENETICS (2005)
Semaphorins command cells to move
RR Kruger et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas et al.
CANCER CELL (2005)
PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival
S Song et al.
NATURE CELL BIOLOGY (2005)
Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors
M De Palma et al.
CANCER CELL (2005)
Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis
C Christensen et al.
CANCER RESEARCH (2005)
Sema4D induces angiogenesis through met recruitment by Plexin B1
P Conrotto et al.
BLOOD (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Differential requirement for Plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 Semaphorins
A Yaron et al.
NEURON (2005)
Cellular abnormalities of blood vessels as targets in cancer
P Baluk et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins
CH Gu et al.
SCIENCE (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Semaphorin-3F is an inhibitor of tumor angiogenesis
O Kessler et al.
CANCER RESEARCH (2004)
The semaphorin 4D receptor plexin-B1 is a GTPase activating protein for R-Ras
I Oinuma et al.
SCIENCE (2004)
Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B
JR Basile et al.
CANCER RESEARCH (2004)
Semaphorin-plexin signaling guides patterning of the developing vasculature
J Torres-Vázquez et al.
DEVELOPMENTAL CELL (2004)
The sema domain
E Gherardi et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2004)
PlexinD1 and semaphorin signaling are required in endothelial cells for cadiovascular development
AD Gitler et al.
DEVELOPMENTAL CELL (2004)
Interplay between scatter factor receptors and B plexins controls invasive growth
P Conrotto et al.
ONCOGENE (2004)
Ras GTPases: Integrins' friends or foes?
K Kinbara et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function
G Serini et al.
NATURE (2003)
Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development
CH Gu et al.
DEVELOPMENTAL CELL (2003)
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-II
H Wildiers et al.
BRITISH JOURNAL OF CANCER (2003)
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
S Pennacchietti et al.
CANCER CELL (2003)
Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165
CH Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B
Y Tomizawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
